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ABSTRACT
Wybutosine (yW) is a hypermodified nucleoside
found in position 37 of tRNA
Phe, and is essential for
correct phenylalanine codon translation. yW
derivatives widely exist in eukaryotes and archaea,
and their chemical structures have many species-
specific variations. Among them, its hydroxylated
derivative, hydroxywybutosine (OHyW), is found in
eukaryotes including human, but the modification
mechanism remains unknown. Recently, we
identified a novel Jumonji C (JmjC)-domain-
containing protein, TYW5 (tRNA yW-synthesizing
enzyme 5), which forms the OHyW nucleoside
by carbon hydroxylation, using Fe(II) ion and
2-oxoglutarate (2-OG) as cofactors. In this work, we
present the crystal structures of human TYW5
(hTYW5) in the free and complex forms with 2-OG
and Ni(II) ion at 2.5 and 2.8A ˚ resolutions, respect-
ively. The structure revealed that the catalytic
domain consists of a b-jellyroll fold, a hallmark of
the JmjC domains and other Fe(II)/2-OG oxygenases.
hTYW5 forms a homodimer through C-terminal helix
bundle formation, thereby presenting a large, posi-
tively charged patch involved in tRNA binding. A
comparison with the structures of other JmjC-
domain-containingproteinssuggestedamechanism
for substrate nucleotide recognition. Functional
analyses of structure-based mutants revealed the
essential Arg residues participating in tRNA recogni-
tion by TYW5. These findings extend the repertoire of
the tRNA modification enzyme into the Fe(II)/2-OG
oxygenase superfamily.
INTRODUCTION
Over 100 RNA modiﬁcations have been found throughout
the three phylogenic domains (1), and these modiﬁed nu-
cleosides have signiﬁcant biological roles in maintaining
life. Most of these modiﬁcations exist in transfer RNA
(tRNA), and they confer various chemical properties to
the RNA residues. Wybutosine (yW) and its derivatives
are highly modiﬁed nucleosides characterized by a tricyclic
base and a bulky side chain (2,3) (Figure 1). These nucleo-
sides are located at position 37, adjacent to the 30 position
of the anticodon, of eukaryotic and archaeal tRNA
Phe.
Recent studies have shown that the yW base is important
for the maintenance of translational ﬁdelity. Whereas yW
does not affect the phenylalanylation of tRNA
Phe under
physiological conditions, tRNA
Phe lacking the yW modi-
ﬁcation enhances codon frame shifting (4). Moreover, the
bulky side chain of the yW base signiﬁcantly suppresses
the  1 frame shifting at a phenylalanine codon (5).
Therefore, the bulky and hydrophobic nature of yW
may stabilize the codon–anticodon pairing in the
ribosome through a base-stacking interaction, thereby
ensuring the correct reading frame (6).
Another distinctive feature of the yW modiﬁcation is
the existence of a wide variety of derivatives. At least
ten derivatives reportedly exist in different phylogenetic
groups (7). Among them, hydroxywybutosine (OHyW),
undermodiﬁed hydroxywybutosine (OHyW*) and peroxy-
wybutosine (o2yW) are hydroxylated yW derivatives
found in higher eukaryotes, including human. These
derivatives have a hydroxyl group or hydroperoxide
group at the b position of the bulky chain of the yW base.
The biosynthetic pathway of yW has been well
characterized in yeast (12). At ﬁrst, the guanosine
residue at position 37 is converted into the distinctive tri-
cyclic structure by tRNA G37 methyltransferase, Trm5 (8)
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TYW1 (9,10). Subsequently, aminocarboxyl transferase
TYW2 (11) and methyltransferase TYW3 append the
exocyclic groups in an Ado-Met-dependent manner to
form yW-72 (yW minus 72Da) (Figure 1). Finally,
TYW4 attaches both the methyl and methoxycarbonyl
groups to the aminocarboxyl side chain, to complete yW
formation (12). However, since yeast tRNA
Phe lacks
OHyW, the biosynthetic mechanism for the hydroxylated
yW derivatives remained elusive for over 30 years.
Recently, our group found that the biosynthesis
of OHyW is catalyzed by a novel Jumonji C (JmjC)-
domain-containing protein (13), TYW5 (tRNA
yW-synthesizing enzyme 5). The JmjC domain was origin-
ally discovered in histone demethylases (14), which have
important roles in the epigenetic regulation of gene expres-
sion, to control cell fate and identity. The JmjC-domain-
containing histone demethylases catalyze the removal of
the methyl group attached to the lysine e-amino group in
histones, through an oxidative reaction that requires Fe(II)
and 2-oxoglutarate (2-OG) as cofactors. The JmjC domain
is also found in other proteins, such as factor inhibiting
hypoxia inducible factor 1 (FIH), which hydroxylates the
b carbon of the Asn side chain in the hypoxia inducible
factor (Hif) 1a transcription factor, thereby regulating the
hypoxic response (15). Furthermore, these JmjC-domain-
containing proteins belong to a large superfamily of Fe(II)/
2-OG dependent oxygenases, which have a variety of roles
in nutrient acquisition, antibiotic synthesis and alkylated
nucleic acid repair (16). Among the JmjC-domain-
containing protein family members, the structure of
FIH shows the highest sequence similarity to TYW5
(26% identity to human TYW5). TYW5 also shares func-
tional similarity to FIH (i.e. hydroxylates the b carbon
of the amino-acid derived side chain of yW), and thus is
considered to catalyze hydroxylation by a similar mechan-
ism to that of FIH. Actually, our functional analysis
demonstrated that TYW5 catalyzes Fe(II)/2-OG-
dependent hydroxylation (17). Furthermore, we found
that TYW5 hydroxylates the precursor of yW, yW-72
(Figure 1A), but not yW (Figure 1D), suggesting that the
hydroxylation by TYW5 occurs prior to the modiﬁcation
byTYW4.Consistentwiththeseﬁndings,arecentbioinfor-
matics analysis also predicted that TYW5 is involved in
OHyW formation (18). However, the tRNA recognition
manner and the hydroxylation mechanism by TYW5
have remained elusive.
To address these questions, we solved the crystal struc-
tures of human TYW5 (hTYW5) in the free and complex
forms with 2-OG and Ni(II) ion at 2.5 and 2.8A ˚ reso-
lutions, respectively. The structures revealed that
hTYW5 consists of a C-terminal helix bundle and an
N-terminal catalytic domain, which shares a similar
b-jellyroll fold with the other JmjC-domain-containing
proteins and the Fe(II)/2-OG dependent oxygenases.
Based on a structural comparison with the active site of
FIH, we found that two Arg residues, speciﬁcally
conserved among the TYW5s, are located in the active
site. The structure-based mutational analysis revealed
that these two Arg residues are essential for tRNA recog-
nition. In addition, homodimer formation through the
C-terminal helix bundle is crucial for the hydroxylation
activity. These results provide structural insights into the
mechanism of Fe(II)/2-OG dependent hydroxylation and
tRNA recognition by TYW5.
MATERIALS AND METHODS
Cloning, expression and puriﬁcation of human TYW5
proteins
The gene encoding human TYW5 was cloned into the
NdeI/BamHI sites of a modiﬁed pET28a vector
(Novagen), with the thrombin site replaced by the
PreScission Protease site (GE Healthcare). The protein
was overexpressed in the Escherichia coli C41(DE3) strain
(Lucigen) transformed with the pRARE plasmid
(Novagen). Escherichia coli cells were grown to an
OD600=0.8, and then the expression was induced by
0.5mM isopropyl b-D-thiogalactopyranoside (IPTG),
followed by cultivation for 18h at 20 C. The cells were
harvested by centrifugation, resuspended in buffer
(50mM Tris–HCl, pH 8.0, 150mM NaCl, 10mM imid-
azole, 1mM PMSF and 5mM 2-mercaptoethanol),
sonicated, and then centrifuged. The supernatant was
applied to a Ni–NTA Superﬂow column (Qiagen). The
eluted fractions were collected and dialyzed against
50mM Tris–HCl, pH 8.0, containing 150mM NaCl and
1mM DTT, and then applied to a Resource Q column
(GE Healthcare). The ﬂow-through fractions, containing
the enzyme activity, were collected, concentrated by ultra-
ﬁltration, and loaded onto a HiLoad 16/60 Superdex 200
column (GE Healthcare) equilibrated in 20mM Tris–HCl
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Figure 1. Biosynthetic pathway of wybutosine. The chemical structures
of (A) 7-(a-amino-a-carboxypropyl)wyosine (yW-72), (B) undermodiﬁed
hydroxywybutosine (OHyW*), (C) hydroxywybutosine (OHyW) and
(D) wybutosine (yW) are shown.
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ThepuriﬁedhTYW5fractionselutedfromthegel-ﬁltration
column were collected and concentrated to 10mgml
 1
with an Amicon Ultra-4 ﬁlter (Millipore). The protein
purity was assessed by SDS–PAGE. To obtain the
selenomethionine-labeled proteins, the methionine-
auxotroph E. coli strain B834(DE3) CodonPlus was
transformed with the same plasmid. The cells were
cultivated in M9 minimum medium containing 50mgml
 1
selenomethionine, and the protein was puriﬁed in the same
manner as native hTYW5.
Crystallization and data collection
The native crystals were obtained by the sitting-drop
vapor diffusion method. The drops were prepared by
mixing 1ml of a 10mgml
 1 TYW5 solution and 1mlo f
the reservoir solution, containing 200mM potassium thio-
cyanate and 10% (w/v) PEG 3350. Crystallization was
performed at 20 C by the sitting drop vapor diffusion
method. Crystals suitable for structural analysis
appeared within 3 days. The selenomethionine-labeled
crystals were obtained by the micro-seeding technique,
using the native crystal as a seed, under the same crystal-
lization conditions as for the native protein. Crystals
were transferred stepwise to the harvesting solution,
240mM potassium thiocyanate and 12% (w/v) PEG
3350, containing 30% (v/v) glycerol as a cryoprotectant
and were ﬂash-cooled in a liquid nitrogen stream at 100K.
To obtain the cofactor-bound crystals, the hTYW5
crystals were soaked for 3h in a harvest solution, contain-
ing 1mM NiCl2, 10mM 2-OG, 240mM potassium
thiocyanate and 12% (w/v) PEG 3,350.
Data collection, structure determination and reﬁnement
X-ray diffraction data were collected at 100K on beamline
BL41XU at SPring-8 and beamline NW12A at the Photon
Factory Advanced Ring (Tsukuba, Japan). Diffraction
data were processed with the HKL2000 program
(HKL Research). The structure was solved by the MAD
method, using the selenomethionine-labeled crystal. The
16 selenium sites were initially located by the programs
SHELXC and SHELXD (19), and the initial phases
were calculated by using SHARP/autoSHARP (20),
followed by automated model building using RESOLVE
(21). The resultant model was reﬁned by using the 2.80-A ˚
resolution data. The model was further manually built
with COOT (22) and reﬁned with PHENIX (23).
Molecular graphics were illustrated with CueMol (http://
www.cuemol.org/). Statistics on data collection, phasing
and reﬁnement are provided in Table 1 and 2.
Site-directed mutagenesis
Site-directed mutagenesis of hTYW5 was performed with
the plasmid pTYW5, according to the manufacturer’s
instructions (Stratagene). Introduced mutations were
conﬁrmed by DNA sequencing. The mutant proteins
were overexpressed in E. coli cells in the same manner as
the wild-type protein, puriﬁed by Ni afﬁnity chromatog-
raphy, and dialyzed against Tris–HCl, pH 8.0, containing
300mM NaCl and 1mM DTT.
Gel ﬁltration chromatography analysis
The puriﬁed hTYW5 and C TYW5 proteins were
loaded onto a HiLoad 16/60 Superdex 200 column
Table 1. Data collection and phasing statistics
Data collection statistics SeMet
X-ray source SPring-8 BL41XU
Wavelength (A ˚ ) Peak Edge Remote high Remote low
0.97911 0.97937 0.96414 0.99509
Unit cell dimensions (A ˚ ,  ) a=165, b=165, c=105  = =  =90
Resolution (A ˚ ) 50–2.5 (2.95–2.49) 50–2.9 (2.95–2.90) 50–2.9 (2.95–2.90) 50–2.9 (2.95–2.90)
Unique reﬂections 33018 (1592) 32694 (1390) 32644 (1454) 32735 (1366)
Redundancy 20.9 (9.1) 10.2 (3.6) 10.5 (4.2) 10.3 (8.3)
Completeness (%) 99.6 (98.9) 98.6 (86.2) 98.7 (90.3) 98.3 (83.6)
I/s(I) 57.2 (3.4) 37.6 (2.0) 37.8 (2.1) 37.7 (2.0)
Rsym 0.078 (0.411) 0.064 (0.403) 0.065 (0.396) 0.063 (0.400)
Phasing statistics
Number of Se sites 16
Phasing power
Iso (cen./acen.) – 1.240/1.378 1.247/1.310 1.334/1.401
Ano 0.574 2.202 0.897 0.129
Rcullis
Iso (cen./acen.) – 0.658/0.675 0.582/0.647 0.567/0.638
Ano 0.933 0.560 0.857 0.996
Mean FOM
Cen./Acen. 0.44079/0.49979
The numbers in parentheses are for the last shell.
Rsym ¼ i I
 
 Ii
  
  =iIi:
Rcullis ¼  FPH+Fp
      Fcalc
H
   = FPH jj :
1578 Nucleic Acids Research, 2011,Vol.39, No. 4(GE Healthcare). The column, which was equilibrated in
20mM Tris–HCl buffer (pH 8.0), containing 300mM
NaCl and 1mM DTT, was run at 0.5ml/min in the
same buffer as that used for crystallization.
Isolation and puriﬁcation of yeast tRNA
Phe
The Saccharomyces cerevisiae BY4742 strain (Mat  ;
his3D1; leu2D0; lys2D0; ura3D0) lacking TYW4
(YOL141w::kanmx4) was obtained from EUROSCARF.
The TYW4 strain was cultivated in YPD (2% peptone,
1% yeast extract and 2% glucose). Total RNA was
extracted from the cultured cells. tRNA
Phe containing
the yW-72 intermediate was isolated and puriﬁed by
reciprocal circulating chromatography (24). The DNA
probe complementary to the yeast tRNA
Phe used in this
study is 50-tgcgaattctgtggatcgaacacaggacct-30.
In vitro activity assays
Hydroxylation of yW-72 was performed basically as
described (17). The reaction mixture (50ml) contained
40mM Tris–HCl (pH 7.6), 10mM KCl, 1mM DTT,
3mM MgCl2, 4mM ascorbic acid, 1.5mM Fe(II)SO4,
4mM 2-OG, 30pmol of tRNA
Phe with yW-72 and
2.8mM recombinant hTYW5p variant. The reactions
wereincubatedfor1hat37 C.ThetRNA
Phewasrecovered
by ISOGEN (Wako), precipitated by ethanol and then
subjected to RNaseA digestion. The RNA fragments
were analyzed by capillary LC nano ESI/MS.
Gel shift assay
The wild-type and mutant TYW5 proteins were mixed
with the annealed yeast tRNA
Phe containing yW-72, at
ratios of 1:1.2 and 2:1.2, respectively. Each mixture was
incubated at 37 C for 15min, and then electrophoresed in
a 5% acrylamide gel (20mA) in TBE buffer, for 1h at
room temperature. The gel was stained with ethidium
bromide and CBB to detect both tRNA and proteins.
RESULTS AND DISCUSSION
Overall structure
The crystal structure of hTYW5 was determined by the
multiwavelength anomalous diffraction (MAD) method,
using a selenomethionine-derivatized crystal (Figure 2).
We also solved the structure of the cofactor-bound
form, by soaking the crystal in buffer containing 2-OG
and NiCl2, the latter of which acts as an inhibitor,
instead of Fe(II) ion. The ﬁnal models of the apo and
cofactor-bound forms were reﬁned at 2.5 and 2.8A ˚ reso-
lutions, to free R-factors of 28.1 and 29.9%, respectively
(Table 1 and 2). The data collection and reﬁnement stat-
istics are summarized in Table 1 and 2. The root mean
square (RMS) deviation between the apo and
cofactor-bound forms is 0.31A ˚ , indicating that they are
almost identical.
The crystal contains two hTYW5 dimers per asymmetric
unit. The overall structure of the hTYW5 protomer
consists of the N-terminal catalytic domain (residues
1–270) and the C-terminal helical domain (residues
271–311) (Figure 2). In the apo and cofactor-bound struc-
tures, one of the dimer molecules contains partially dis-
ordered regions (residues 1–3, 63–66, 71, 92 and 312–315
for chain A). The relatively high R-free factors for both
structures can be ascribed to this structural disorder.
The central core of the catalytic domain contains a
b-strand jellyroll fold, which is homologous to the struc-
tures of the other Fe(II)/2-OG oxygenases and JmjC
domains (13,25). While the structures of the Fe(II)/2-OG
dependent oxygenases typically have a jellyroll fold with
eight b-strands, the jellyroll fold of hTYW5 has only seven
b strands (b7 and b9–b14), which are surrounded
by additional a-helices (aA, aB, aB0, aC, aD, aE),
b-strands (b1–b6), and several loops (Figure 2C). In the
C-terminal domain, the helices aG and aH form extensive
interactions with those of another protomer, thereby
creating an antiparallel four-helix bundle. The physiologic-
al relevance of this dimer formation is discussed below.
Structural comparison with FIH
The amino-acid sequence of hTYW5 shares considerable
sequence similarity (26% identity) with human FIH,
which catalyzes the hydroxylation of the Asn803 residue
of Hif1a (Supplementary Figure S1). FIH belongs to the
JmjC domain-containing protein family, which catalyzes
the hydroxylation using Fe(II) ion and 2-OG as cofactors
(26,27). As expected from the amino-acid sequence simi-
larity, hTYW5 has a similar tertiary structure to FIH, and
shares the core structure with the other JmjC-domain-
containing proteins. A structural similarity search
with the DALI program (28) also indicated that the
structure of hTYW5 is highly similar to that of FIH
(r.m.s.d.=1.98A ˚ for 210 Ca atoms) (Figure 3).
Table 2. Structure reﬁnement statistics
Data collection statistics Apo form Cofactor bound form
X-ray source PF NW12 SPring-8 BL41XU
Wavelength (A ˚ ) 1.0 1.48505
Resolution (A ˚ ) 50–2.5 (2.54–2.5) 50–2.8 (2.85–2.8)
Unique reﬂections 49257 (2349) 36950 (1776)
Redundancy 9.0 (4.3) 19.0 (5.7)
Completeness (%) 97.6 (94.9) 99.6 (98.1)
I/s(I) 28.0 (2.6) 56.4 (2.5)
Rsym 0.075 (0.392) 0.082 (0.480)
Reﬁnement statistics
Resolution (A ˚ ) 50–2.5 50–2.8
No. of reﬂections (all/test) 49227/2462 36782/1840
Rwork/Rfree 0.2196/0.2812 0.2349/0.2993
Number of atoms
Non-hydrogen 9288 9057
Water 0 0
RMSD of
Bond lengths (A ˚ ) 0.009 0.01
Bond angles ( ) 1.257 1.343
Average B factor (A ˚ 2) 77.7 86.9
Ramachandran plot
Most favored (%) 85.7 83.3
Allowed region (%) 14.3 16.6
Disallowed region (%) 0.0 0.1
The numbers in parentheses are for the last shell. Rwork=|Fo–Fc|/
Fo for reﬂections of work set. Rfree=|Fo–Fc|/Fo for reﬂections of
test set (5% of total reﬂections).
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Figure 3. Structural comparison of hTYW5 and FIH. (A) The overall structure of hTYW5. One protomer of the dimer is colored as in Figure 2,
while the other protomer is grey. The directions of the catalytic pockets are indicated by arrows. A close-up view of the C-terminal helices (aG and
aH) of hTYW5, which form the anti-parallel four-helix bundle, is shown below. (B) The overall structure of human FIH. The crystal structure of
FIH (PDB ID: 1mze) is shown in a ribbon representation. The N-terminal catalytic domain, the C-terminal helix bundle and the b-jellyroll fold are
colored purple, orange and green, respectively. The directions of the catalytic pockets are indicated by arrows. (C) and (D) Structural comparison of
the active sites of (C) hTYW5 and (D) FIH. The crystal structures of the cofactor-bound forms of hTYW5 and FIH complexed with substrate
peptide (PDB ID: 1h2k) are shown in ribbon representations. The long loop between b4 and b5 of FIH is colored orange. The TYW5-speciﬁc short,
basic b-turn, and the long insertions between b6 and aD and between b14 and aG, which adopt different structures from those in FIH, are
highlighted in blue and green, respectively. The substrate peptide of FIH is shown in pink.
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Figure 2. Overall structure of hTYW5. (A) and (B) Ribbon representations of the (A) hTYW5 dimer and (B) protomer. The N-terminal catalytic
domain, the b-jellyroll fold and the C-terminal helix bundle are colored pink, cyan and yellow, respectively. (C) A secondary structure topology
diagram of human TYW5. The a-helices and b-strands are represented by circles and triangles, respectively. The N-terminal catalytic domain, the
b-jellyroll fold and the C-terminal helix bundle are colored as in Figures 2A and B. The jellyroll cores of the other 2-OG dependent oxygeneses
generally comprise eight b-strands, whereas hTYW5 has only seven strands. The missing b-strand (b8) is represented by the dashed-line triangle.
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hTYW5 and FIH. First, although both hTYW5 and FIH
have a-helical C-terminal domains that form the
dimerization interface, the arrangements of these helices
are completely different (Figure 3A and B). The four a
helices of the C-terminal domains of FIH adopt a
rhomboid-shaped arrangement, whereas those of hTYW5
form an anti-parallel four-helix bundle. As a consequence,
the relative orientations of the catalytic domains of the
dimers are also different. The two entrances of the active
sites of the FIH dimer are oriented in opposite directions,
whereas those of the hTYW5 dimer are oriented in nearly
perpendicular directions. Secondly, the structures around
the entrance of the active site are different (Figure 3C and
D). In the FIH-peptide complex structure, the substrate
peptide is sandwiched between the b sheet (b7 and b8)
and the long loops (loops between b4 and b5 and
between b10 and b11). In contrast, in hTYW5, these
loops are replaced by a short basic loop and a short basic
b-turn, respectively. These structural differences may
reﬂect the substrate differences between hTYW5 and FIH
(i.e. nucleotide and peptide, respectively). Moreover, in
hTYW5, the long loop insertions between b6 and aD and
between b14 and aG occupy the entrance of the catalytic
pocket. Interestingly, in FIH, the corresponding entrance
siteisempty,andisusedasthebindingsiteforthesubstrate
peptide (Figure3CandD).Therefore, thisloop insertion in
hTYW5 occupies a similar position to the substrate peptide
in the FIH complex, thus allowing the substrate binding
site to have a smaller, deeper pocket suitable for
accommodating the yW-72 base. It is also interesting to
note that a similar substrate switching mechanism exists
between TYW4 and protein phosphatase methyltrans-
ferase 1 (PPM1): TYW4 methylates the acp side chain of
theyWbaseprecursor(Figure1),whilePPM1catalyzesthe
methylation of the peptide substrate (29,30). In TYW4, a
b-hairpinintheC-terminalKelch-repeatdomainisinserted
into the entrance of the catalytic pocket of the N-terminal
domain, thus switching the peptide substrate (in the case
of PPM1) to a nucleobase substrate by reducing the space
in the catalytic pocket (12). Such a substrate switching
mechanism may be a general strategy in the evolution of
RNA modiﬁcation enzymes from peptide modiﬁcation
enzymes.
The active site structure of hTYW5
The active site of the typical Fe(II)/2-OG oxygenases is
located in the center of the b jellyroll fold, and consists of
a highly conserved His-X-(Asp/Glu)-Xn-His signature
motif. These conserved residues provide three chemical
groups to chelate the Fe(II) ion, while two additional
chelating groups are supplied by the C-1 carboxylate
and C-2 ketone groups of 2-OG.
In the crystal structure of the cofactor-bound TYW5, we
observedastrongpeakintheanomalousdifferenceFourier
map, calculated from the dataset collected at the peak
wavelength of the Ni K-shell absorption edge. Therefore,
we assigned this peak to the Ni(II) ion bound to the cata-
lytic site (Figure 4A). As in the typical Fe(II)/2-OG
oxygenases, the Ni(II) ion is coordinated by the signature
motifofHis160,Asp162(ontheloopconnectingstrandsb7
and b9) and His235 (on b13), and mimics the physiological
cofactor, Fe(II) ion (Figure 4A). Furthermore, in this
cofactor-bound form, we clearly observed an electron
density peak corresponding to the 2-OG cofactor
(Figure 4A). The bound 2-OG cofactor is recognized
by the conserved residues among TYW5 and FIH in the
catalytic pocket, where the e-amino group of Lys175 and
the hydroxyl group of Tyr106 hydrogen bond to the C-5
carboxyl moiety of 2-OG, and the side chain amino group
of Asn166 hydrogen bonds to the C-1 carboxyl moiety of
2-OG (Figure 4A). The side-chain conformations of these
residues in hTYW5, as well as the 2-OG recognition
manner, are also similar to those in FIH.
In contrast, some residues are speciﬁcally conserved
among the TYW5 enzymes. In particular, Arg108 and
Arg149, residing near the active site, are strictly conserved
(Supplementary Figure S1). These Arg residues corres-
pond to Asp148 and Leu188 in FIH, respectively. To elu-
cidate the function of these Arg residues, we substituted
them with Ala residues (R108A and R149A) and
measured their hydroxylation activities (Figure 5B). The
results showed that both mutations abolished the ability
to form OHyW* from yW-72-containing tRNA
Phe,
indicating that these residues are essential for the enzym-
atic activity. To further clarify the role of these Arg
residues, we performed a tRNA gel shift analysis with
the mutants. Both mutants lacked the ability to bind
tRNA (Figure 5A), suggesting that these Arg residues
are involved in the tRNA recognition. Given that the
binding mode of the acp side chain of the yW-72 base to
TYW5 is the same as that of the target Asn residue in the
substrate peptide to FIH, we can predict that these Arg
residues are located close to the carboxyl group of the acp
side chain. Therefore, these residues are likely to be
involved in the recognition of the substrate yW-72 base
moiety of tRNA. This hypothesis is in good agreement
with the previous observation that hTYW5 has almost
no hydroxylation activity for the fully modiﬁed yW base
(17), in which the carboxyl group of the acp side chain
is methylated and thus can no longer form a salt bridge
with the conserved Arg residues.
Based on the present crystal structure and functional
analysis, as well as the proposed catalytic mechanism for
other Fe(II)/2-OG oxygenases (25), we propose the fol-
lowing hydroxylation mechanism by TYW5 (Figure 4C).
At ﬁrst, TYW5 binds Fe(II) ion, 2-OG, molecular oxygen,
and the yW-72 residue at position 37 of the tRNA
Phe pre-
cursor. In this stage, the carboxyl group of yW-72 is
recognized by the guanidinium group of the conserved
Arg149. Next, the highly reactive oxoferryl species is
generated from Fe(II), 2-OG and O2, by converting
2-OG into succinate and carbon dioxide. Finally, the
reactive oxygen of the oxoferryl species attacks the b
carbon of the acp side chain of yW-72, to form OHyW*.
Structural comparison with other JmjC-domain-containing
proteins and Fe(II)/2-OG oxygenases
The most prevalent JmjC-domain-containing proteins are
histone demethylases, which catalyze the hydroxylation of
Nucleic Acids Research,2011, Vol.39, No. 4 1581the methyl group of the target methyl-lysine residues in
histones, and the unstable hydroxymethyl lysine thus
generated is then spontaneously converted into formalde-
hyde and lysine. The crystal structure of JMJD2A, which
is involved in the demethylation of di- and tri-methylated
H3K9 and H3K36, was reported (31,32). As expected
from the sequence similarity, hTYW5 also has a similar
b-jellyroll core structure to that of JMJD2A (Figure 6A
and C) (r.m.s.d.=2.87A ˚ for 185 Ca atoms). The struc-
tural arrangements of the catalytic residues that ligate the
Fe(II) and 2-OG cofactors are also well conserved between
hTYW5 and JMJD2A. However, the structural similarity
to JMJD2A is limited to the core structure, and the sur-
rounding structural elements around the b-jellyroll fold
are different. JMJD2A also has an additional a-helical
C-terminal domain, but the arrangement of the a helices
is completely different from those of both hTYW5 and
FIH (Figure 6A, B and C). This is consistent with the
fact that this C-terminal domain of JMJD2A is not
involved in the dimer formation. Furthermore, the result-
ant molecular surface and its electrostatic potential
around the catalytic pocket are completely different; the
catalytic pocket of hTYW5 is positively charged, whereas
that of JMJD2A is negatively charged (Figure 6A and C).
This is reasonable, because JMJD2A recognizes the posi-
tively charged histone tail, whereas hTYW5 binds the
negatively charged tRNA.
AlkB, another member of the Fe(II)/2-OG oxygenases,
recognizes the polynucleotide chain. AlkB catalyzes oxi-
dative dealkylation, to repair alkylated DNA (33). AlkB
and TYW5 share functional similarity, in that both
enzymes recognize a nucleotide base and hydroxylate
its exocyclic alkyl carbon atom. However, AlkB is not
classiﬁed as a JmjC-domain-containing protein, and its
amino-acid sequence is highly divergent from that of
TYW5. As a result, the structure of AlkB (34) is also
completely different from that of TYW5, and only the
arrangement of the secondary structural elements of the
b-jellyroll fold is conserved (Figure 6A and D)
(r.m.s.d.=2.43A ˚ for 118 Ca atoms). However, interest-
ingly, the surface of AlkB has a positively charged patch
for binding to the phosphate backbone of the poly-
nucleotide chain, which is reminiscent of the positively
charged patch around the catalytic pocket in hTYW5
(Figure 6D). A putative tRNA recognition mechanism
by this positively charged patch in TYW5 is discussed
below.
Dimer formation by the C-terminal helix bundle domain
and possible tRNA recognition mechanism
The C-terminal domain, containing two anti-parallel
a-helices, forms extensive interactions with that of
another protomer, through the core hydrophobic inter-
actions augmented by the surrounding hydrogen-bonding
A
C
B
Figure 4. The active site and catalytic mechanism of TYW5. (A) An unbiased Fo–Fc omit map around 2-OG (contoured at 3.0s) and an anomalous
Fourier map around the nickel ion (contoured at 20.0s) are shown in blue and red, respectively. The omit map was calculated after removing the
2-OG cofactor from the model. (B) The active site of FIH complexed with the substrate peptide. The same color code as in Figure 3B is used. The
substrate peptide of FIH is colored red. FIH catalyzes the hydroxylation of the b-carbon of Asn803, which is encircled with the b carbon indicated
by an arrow. (C) Proposed catalytic mechanism by hTYW5.
1582 Nucleic Acids Research, 2011,Vol.39, No. 4interactions (Figure 3A). The resultant area buried by
the interaction is 1365A ˚ 2 per protomer. To determine
whether the dimer observed in the crystal is also formed
in solution, we subjected the wild-type (wt) hTYW5 and
the C-terminal helix bundle deletion mutant (C hTYW5)
to gel ﬁltration chromatography. The results revealed that
wt hTYW5 also forms a dimer in solution, whereas the
C hTYW5 mutant behaves as a monomer, indicating the
importance of the C-terminal helix bundle for dimer
formation (Figure 5C). Furthermore, we analyzed the
tRNA-binding ability and the hydroxylation activity
of the C hTYW5 mutant, by a gel shift assay and an
LC/MS analysis (Figure 5A and B), respectively. The C
hTYW5 mutant showed drastically decreased tRNA
binding and hydroxylation activities, as compared to
those of the wt hTYW5. Therefore, these results suggest
that the dimer formation mediated by the C-terminal
domain is essential for the tRNA recognition and
subsequent RNA modiﬁcation by hTYW5.
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Figure 5. Mutant analysis. (A) Gel-shift assay. The wild-type hTYW5
and mutant hTYW5 (R108A, R149A and C hTYW5) proteins were
mixed with tRNA
Phe containing the yW-72 modiﬁcation at molar ratios
of 1:1.2 and 2:1.2, respectively, and then analyzed. The gel was stained
with ethidium bromide. The tRNA band and the protein/tRNA
complex band are indicated by black and red arrows, respectively.
(B) LC/MS analysis. LC/MS fragment analyses of RNaseA-digested
tRNA
Phe with yW-72, treated with recombinant wild-type TYW5 and
mutant hTYW5 (R108A, R149A and C hTYW5) in the presence of
2-OG and Fe
2+.( C) Gel ﬁltration chromatography of wild-type
hTYW5 and C hTYW5. The absorbances at 280nm of wild-type
hTYW5 and C hTYW5 are shown as blue and pink lines, respectively.
The molecular mass of the hTYW5 monomer is 36.5kDa. Wild-type
hTYW5 was eluted at the size expected for a dimer, whereas C
hTYW5 was eluted at the size expected for a monomer.
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Figure 6. Structural comparison of (A) TYW5 with other
JmjC-domain-containing proteins, (B) FIH, (C) JMJD2A and Fe(II)/
2-OG dependent oxygenase and (D) AlkB. In each panel, the structure
is shown in both ribbon and surface models. In the ribbon models in
the left column, the core b sheets of the b jellyroll fold are colored
orange. The structures were aligned using the SSM algorithm imple-
mented in COOT (32). In the surface models in the right column, the
molecular surfaces of the positively charged regions are colored blue
and those of the negatively charged regions are colored red, with the
intensity of the color proportional to the local potential calculated by
the program APBS (35). The bound substrates are shown in stick
models. The surfaces around the catalytic pocket are indicated by
circles.
Nucleic Acids Research,2011, Vol.39, No. 4 1583The surface electrostatic potential of hTYW5 revealed
the existence of a large, positively charged patch around
the catalytic pocket (Figure 7A), formed by highly
conserved, basic residues. In contrast, the catalytic
pockets of the other Jmj-C-containing proteins that
interact with polypeptides are not positively charged
(Figure 6A, B and C). Therefore, the positively charged
catalytic pocket of hTYW5 may be involved in the recog-
nition of the tRNA anticodon stem loop, to orient nucleo-
tide 37 correctly within the catalytic site. In addition, a
large, positively charged patch exists on the C-terminal
helix bundle, which is created by the conserved basic
residues (Lys274, Lys281 and Arg284) of the aG helices
of both protomers upon dimer formation (Figure 7A). We
hypothesize that this positively charged patch on the
C-terminal helix bundle is involved in tRNA binding.
Based on the present structure and functional analyses,
we created a docking model of the TYW5–tRNA
Phe
complex, in which the D arm is captured by the positively
charged patch (Figure 7B), and the anticodon loop is
directed into the positively charged catalytic pocket.
Further clariﬁcation of the mechanism of tRNA
Phe recog-
nition by hTYW5 must await the structure determination
of the TYW5–tRNA
Phe complex.
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